awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34407893-1A82E811-BE13-4431-8284-68D4620F1070
Q34407893-1A82E811-BE13-4431-8284-68D4620F1070
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34407893-1A82E811-BE13-4431-8284-68D4620F1070
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus
P2860
Q34407893-1A82E811-BE13-4431-8284-68D4620F1070
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34407893-1A82E811-BE13-4431-8284-68D4620F1070
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
34cca956b7ba718965cf29667436c08a802bdc86
P2860
Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus.